Omar Khaled Alboqai, Bayan Obeidat, Mohammad A Ebqa'ai, Mohammed O Ibrahim, Nermeen Bleedy, Tamara Ibrahim Shafiq Al-Sa'adi, Baha M Abu Salma, Dima Alkadri, Nizar Alrabadi, Mohammed Gamal
{"title":"Central Obesity and Estimated Coronary Heart Disease Risk Among Jordanian Women Aged 30-50 Years: A Framingham Risk Score Analysis.","authors":"Omar Khaled Alboqai, Bayan Obeidat, Mohammad A Ebqa'ai, Mohammed O Ibrahim, Nermeen Bleedy, Tamara Ibrahim Shafiq Al-Sa'adi, Baha M Abu Salma, Dima Alkadri, Nizar Alrabadi, Mohammed Gamal","doi":"10.1155/jnme/3899686","DOIUrl":"https://doi.org/10.1155/jnme/3899686","url":null,"abstract":"<p><strong>Background: </strong>Obesity is a well-established modifiable risk factor for cardiovascular disease (CVD), particularly coronary heart disease (CHD). Its high prevalence among Jordanian women aged 30-50 years highlights the need for early cardiovascular risk assessment to support targeted preventive strategies.</p><p><strong>Objective: </strong>To estimate the 10-year risk of CHD among Jordanian women aged 30-50 years using the Framingham risk score (FRS) and to examine the associations between general obesity, central obesity, cardiometabolic risk factors, and estimated CHD risk.</p><p><strong>Methods: </strong>A cross-sectional study was conducted among 230 Jordanian women aged 30-50 years who were recruited using a multistage cluster sampling technique. Standardized anthropometric measurements, including body weight, height, and waist circumference (WC), were obtained to calculate body mass index (BMI) and waist-to-height ratio (WHtR). Blood pressure was measured according to standardized procedures, and fasting blood samples were analyzed to determine fasting blood glucose and lipid profile parameters. Smoking status and physical activity were assessed using structured questionnaires. The 10-year risk of CHD was estimated using the FRS. Descriptive and inferential statistical analyses were performed to evaluate the associations between obesity indices and estimated CHD risk.</p><p><strong>Results: </strong>General obesity was identified in 39.1% of participants, while 40.9% had central obesity based on WC (≥ 88 cm). Nearly half of the participants (47.0%) were current smokers, and 21.3% reported low levels of physical activity. According to the FRS, 66.1% of participants were classified as having low CHD risk, 16.5% as moderate risk, and 17.4% as high risk. Higher BMI and central obesity were significantly associated with elevated blood pressure, fasting blood glucose, triglyceride levels, and LDL cholesterol, as well as lower HDL cholesterol (all <i>p</i> < 0.001). Smoking, physical inactivity, and both general and central obesity were significantly associated with an increased estimated risk of CHD.</p><p><strong>Conclusion: </strong>Jordanian women aged 30-50 years exhibited a substantial burden of both general and central obesity, accompanied by an increased estimated risk of CHD. These findings underscore the importance of routine cardiovascular risk assessment and comprehensive lifestyle interventions focusing on weight management, smoking cessation, and regular physical activity. Because the FRS has not been specifically validated in Jordanian women, the estimated absolute cardiovascular risk should be interpreted with caution.</p>","PeriodicalId":16587,"journal":{"name":"Journal of Nutrition and Metabolism","volume":"2026 ","pages":"3899686"},"PeriodicalIF":4.0,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13769039/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
H Shakoor, C Platat, A Riabinin, A Parveen, J Kizhakkayil, B Sadek, C Dsouza, E Adeghate, Y Statsenko
{"title":"Impact of Training Settings on Hormonal Status, Body Weight, and Glucose Levels in Wistar Rats.","authors":"H Shakoor, C Platat, A Riabinin, A Parveen, J Kizhakkayil, B Sadek, C Dsouza, E Adeghate, Y Statsenko","doi":"10.1155/jnme/8668755","DOIUrl":"10.1155/jnme/8668755","url":null,"abstract":"<p><p>This study explored how different physical training settings affect hormonal and metabolic responses in male Wistar rats (<i>n</i> = 28). Rats were randomly assigned to a control (no-exercise), ET4 (4-week training), ET8 (8-week training), DT4 (4 week training and then 4-week detraining), and PCA (4-week training and then 4-week detraining + PCA). Serum hormones, muscle secretions, glycogen, pyruvate, HK, and PFK were analyzed. The groups were compared using one-way ANOVA, with Cohen's d and Pearson's correlation for associations. Machine learning models predicted body weight and glucose levels from training settings. Eight-week training significantly elevated IL-6 (<i>p</i> = 0.021, <i>d</i> = 2.04), IGF-1 (<i>p</i> = 0.012, <i>d</i> = 1.96), cortisol (<i>p</i> = 0.0277, <i>d</i> = 1.677) and testosterone-to-cortisol (<i>p</i> = 0.009, <i>d</i> = 2.465), and leptin (<i>p</i> = 0.001, <i>d</i> = 3.098) vs. control. Furthermore, 4-8 weeks of training resulted in a significant increase in the number of skeletal muscle satellite cells compared with the respective control groups. Myostatin was reduced with 4-week training (<i>p</i> = 0.002, <i>d</i> = 2.273) and further after 8 week (<i>p</i> = 0.014, <i>d</i> = 1.613). PCA supplementation increased pyruvate levels (<i>p</i> = 0.005, <i>d</i> = 1.31). Key correlations were found between IL-6 and ghrelin (<i>r</i> = -0.52, <i>p</i> = 0.005), FGF-21 and T/A (<i>r</i> = 0.47, <i>p</i> = 0.012), and IGF-1 with aldosterone (<i>r</i> = 0.47, <i>p</i> = 0.012) and cortisol (<i>r</i> = -0.50, <i>p</i> = 0.006). Machine learning revealed total training weeks as the strongest predictor of body weight (XGBoost), while recent training (last 2 weeks) best predicted glucose levels (LightGBM). Metabolic adaptations emerged within 2 weeks, including improvement in IL-6, IGF-1, ghrelin, cortisol, aldosterone, and blood glucose, with effects amplified by 8 weeks of training. PCA supplementation regulated energy metabolism during detraining.</p>","PeriodicalId":16587,"journal":{"name":"Journal of Nutrition and Metabolism","volume":"2026 ","pages":"8668755"},"PeriodicalIF":4.0,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13727895/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149322249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ahmed Hussein Hasan Alshihmani, Mahmoud Mahmoudi, Ramiar Kamal Kheder, Maryam Ahmadi-Khorram, Afsane Fadaee, Dariush Haghmorad, Mohammad Hossein Shams, Seyed-Alireza Esmaeili
{"title":"Immunomodulatory Probiotics in Psoriasis: Effects on the Gut-Skin-Immune Crosstalk and Systemic Inflammation: Immunomodulatory Probiotics and Psoriasis Disease.","authors":"Ahmed Hussein Hasan Alshihmani, Mahmoud Mahmoudi, Ramiar Kamal Kheder, Maryam Ahmadi-Khorram, Afsane Fadaee, Dariush Haghmorad, Mohammad Hossein Shams, Seyed-Alireza Esmaeili","doi":"10.1155/jnme/7365660","DOIUrl":"10.1155/jnme/7365660","url":null,"abstract":"<p><p>Psoriasis is a chronic inflammatory skin disorder characterized by dysregulated immune responses and excessive keratinocyte proliferation, with substantial effects on patients' quality of life. Evidence suggests that the gut microbiota and the gut-skin-immune axis may contribute to systemic inflammation and immune dysregulation associated with psoriasis. This narrative review examines the potential immunomodulatory role of probiotics in psoriasis, with particular emphasis on strain-specific biological effects and the mechanisms linking intestinal microbial modulation to psoriasis-related inflammation. Probiotics may influence intestinal microbial composition, epithelial barrier integrity, microbial metabolite production, and immune signaling. Clinical studies have reported potential improvements in psoriasis severity, inflammatory biomarkers, or quality of life following probiotic supplementation; however, the available evidence remains limited and heterogeneous, with substantial variation in probiotic strains, formulations, doses, treatment durations, concomitant therapies, and clinical outcomes. Unlike previous systematic reviews and meta-analyses that primarily summarize clinical outcomes, this review integrates clinical findings with strain-specific mechanistic and experimental evidence to provide a biologically contextualized interpretation of the potential role of probiotics in psoriasis.</p>","PeriodicalId":16587,"journal":{"name":"Journal of Nutrition and Metabolism","volume":"2026 ","pages":"7365660"},"PeriodicalIF":4.0,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725134/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149322248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jingxu Nie, Linlin Fan, Juan Du, Weihua Wang, Jun Li, Lianzhen Chen
{"title":"Natural Fish Oil Versus Purified Fish Oil: Composition, Efficacy, and Applications.","authors":"Jingxu Nie, Linlin Fan, Juan Du, Weihua Wang, Jun Li, Lianzhen Chen","doi":"10.1155/jnme/5029849","DOIUrl":"10.1155/jnme/5029849","url":null,"abstract":"<p><p>This review proposes a purity-bioavailability-indication framework to systematically differentiate natural fish oil (NFO) and purified fish oil (PFO) and guide clinical decision-making. We categorize fish oil formulations along a therapeutic gradient from nutritional maintenance to targeted intervention, with molecular structure stratification based on bioavailability and safety profiles. NFO retains natural triglyceride structures with superior absorption kinetics but lower ω-3 polyunsaturated fatty acid (PUFA) purity, positioning it for maintenance nutritional supplementation. PFO, through advanced purification, achieves higher purity in ethyl esters (EEs), free fatty acids (FFAs), and re-esterified triglycerides (rTG) forms. The rTG structure uniquely combines high purity with enhanced bioavailability, bridging the gap between NFO and conventional PFO. Within the PFO category, our framework distinguishes eicosapentaenoic acid ethyl ester (EPA-EE) as the evidence-based choice for atherosclerotic cardiovascular disease (ASCVD) risk reduction, combinations of EPA and docosahexaenoic acid (EPA/DHA) as neutral for cardiovascular outcomes, and rTG as the bioavailable alternative for enteral therapeutic applications. For parenteral nutrition, PFO-based lipid emulsions provide formulation and operational advantages. In summary, this framework identifies a fundamental trade-off between natural matrix preservation (NFO) and purity/bioavailability optimization (PFO). PFO, particularly high-purity EPA-EE formulations, demonstrates established efficacy in cardiovascular risk reduction, while rTG offers superior bioavailability with comparable clinical promise; both PFO formulations show advantages in parenteral nutrition. High-dose ω-3 formulations, regardless of EPA monotherapy or EPA/DHA combination, carry a dose-dependent atrial fibrillation risk that warrants age-stratified assessment. NFO remains preferable for general nutritional supplementation given its favorable tolerability and preservation of natural antioxidants. Selection between NFO and PFO should be guided by clinical indication, required dosage, and arrhythmia risk stratification.</p>","PeriodicalId":16587,"journal":{"name":"Journal of Nutrition and Metabolism","volume":"2026 ","pages":"5029849"},"PeriodicalIF":4.0,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13671099/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149216507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F Ferragina, Y Ferro, I Barca, A R Sottile, R Pujia, A Arrotta, T Montalcini, M G Cristofaro
{"title":"Perioperative Immunonutrition and Postoperative Recovery Patterns in Oral Squamous Cell Carcinoma Surgery: A Prospective Observational Cohort Study.","authors":"F Ferragina, Y Ferro, I Barca, A R Sottile, R Pujia, A Arrotta, T Montalcini, M G Cristofaro","doi":"10.1155/jnme/4971173","DOIUrl":"10.1155/jnme/4971173","url":null,"abstract":"<p><strong>Background: </strong>Malnutrition and sarcopenia negatively affect outcomes in patients undergoing surgery for oral squamous cell carcinoma (OSCC). Immunonutrition has been proposed to improve perioperative recovery, but evidence remains limited, particularly in oral cancer surgery. The objective of this study was to evaluate postoperative weight changes, muscle status, complications, and hospital stay in patients with OSCC who received a perioperative immune-nutritional protocol.</p><p><strong>Methods: </strong>We conducted a single-center prospective observational cohort study including 22 patients surgically treated for OSCC between January 2022 and January 2024. All patients received perioperative immunonutrition administered orally or via nasogastric tube at four timepoints (T0: preoperative; T1: immediate postoperative; T2: discharge; T3: 30 days). All patients underwent anthropometric measurements, muscle strength assessment, and bioelectrical impedance analysis (muscle mass, phase angle, and total body water). All evaluations were performed at each study timepoint.</p><p><strong>Results: </strong>The study population consisted of 62% females, with a mean age of 65 ± 10 years, and 17% of patients presented clinically relevant nutritional risk at baseline. Patients experienced a mean weight loss of 2.1 kg during the early postoperative hospitalization period, followed by a partial recovery of 1.2 kg within 30 days (<i>p</i> < 0.001). Phase angle and handgrip strength remained stable throughout the follow-up, indicating preserved cellular integrity and muscle function. Wound dehiscence occurred in 38% but healed without major sequelae. The average length of hospital stay was 13.8 ± 6.9 days. Although the results are lower than those reported in the literature on similar OSCC cases, caution is warranted when comparing due to differences in design and perioperative management.</p><p><strong>Conclusions: </strong>In patients undergoing surgery for OSCC, the perioperative immune-nutritional protocol was associated with minimal postoperative weight loss and stable functional muscle status. Additionally, the postoperative recovery patterns in this cohort were favorable, and the complication rates were low.</p><p><strong>Clinical implications: </strong>Integrating immunonutrition into enhanced recovery (ERAS) pathways may optimize surgical outcomes, reduce hospitalization costs, and improve patient quality of life.</p>","PeriodicalId":16587,"journal":{"name":"Journal of Nutrition and Metabolism","volume":"2026 ","pages":"4971173"},"PeriodicalIF":4.0,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13639927/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149111105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prevalence of Childhood Stunting and Its Associated Factors in Bangladesh: Quantile Regression Modeling Approach.","authors":"Israt Jahan, Md Israt Rayhan, Kanis Fatama Ferdushi, Mirza Nazmul Hasan, Nahid Sultana","doi":"10.1155/jnme/5517189","DOIUrl":"https://doi.org/10.1155/jnme/5517189","url":null,"abstract":"<p><strong>Background: </strong>Stunting is a key public health concern among under-five children in Bangladesh. It affects approximately one-quarter of children under 5 years of age, which is higher than global averages and insufficient to meet the goal of the World Health Organization (WHO) for reducing stunting to 15%. So, further research is needed to better understand the current dynamics of stunting and to develop pragmatic policies based on the most recent nationwide data which will provide valuable insights into the factors influencing stunting in Bangladesh. This study investigates the prevalence and risk factors of stunting among children under five using the most recent national data.</p><p><strong>Methods: </strong>Data were analyzed from the Bangladesh Demographic and Health Survey (BDHS) 2022. The data collection for the 2022 BDHS took place from June 27, 2022, to December 12, 2022. This survey used stratified sampling and selection is made in two stages. In the first stage, 675 enumeration areas (EAs) were picked from each stratum and a fixed number of 45 households per EA were selected in the second stage. The final data contain 8784 children under 5 years. After cleaning the flagged cases and missing values of related variable, the dataset comprises information on weighted sample of 3664 children. In bivariate analysis, a nonparametric Kruskal-Wallis test was employed for violating the parametric assumptions. Subsequently, robust quantile regression models were utilized to evaluate the impact of various independent variables on height-for-age Z-score (HAZ) across different quantiles.</p><p><strong>Results: </strong>Results reveal that the prevalence of stunting was 23%, with 17.8% and 5.2% classified as moderately and severely stunted, respectively. The quantile regression analysis shows significant heterogeneity in the determinants of child growth across the HAZ distribution. Predictors with stronger effects among moderately and severely stunted children (lowest HAZ quantile) include older child age, high birth order, twin births, low maternal BMI, low maternal education, lack of media exposure, low paternal education, and poor household wealth. Older child age was consistently associated with lower HAZ across all quantiles. The positive effects of maternal education, maternal overweight status, media exposure, and household wealth index are strongest at the lower HAZ quantiles. Children with higher birth orders have lower HAZ through all quantiles compared to first-born children. Twin births are associated with lower HAZ in the lower and middle quantiles. Several predictors, particularly maternal education, maternal nutritional status, and household wealth, exhibit higher prognostic value for severe and moderate stunting than for children in higher HAZ quantiles.</p><p><strong>Conclusions: </strong>Stunting remains a significant public health concern among children in Bangladesh. The effects of child, maternal, household, and h","PeriodicalId":16587,"journal":{"name":"Journal of Nutrition and Metabolism","volume":"2026 ","pages":"5517189"},"PeriodicalIF":4.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13628568/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149111078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Irene Peral-Sanchez, Eda Sezer, Diego A Ojeda, Philip C Calder, Patrick C McHugh, Rachel Morris, Jeanette L Norman, Jon Ward, Tom P Fleming, Judith J Eckert, Neil R Smyth, Sandrine Willaime-Morawek
{"title":"Maternal High-Fat Diet, During Preimplantation or Gestation/Lactation, Alters Mouse Offspring Metabolic, Molecular and Locomotor Phenotypes.","authors":"Irene Peral-Sanchez, Eda Sezer, Diego A Ojeda, Philip C Calder, Patrick C McHugh, Rachel Morris, Jeanette L Norman, Jon Ward, Tom P Fleming, Judith J Eckert, Neil R Smyth, Sandrine Willaime-Morawek","doi":"10.1155/jnme/5286440","DOIUrl":"https://doi.org/10.1155/jnme/5286440","url":null,"abstract":"<p><p>Maternal nutrition during offspring development influences the offspring physiology and risk of long-term chronic disease. Here, we investigate the effects of maternal high-fat diet during distinct developmental windows (preimplantation alone, EmbHFD; or throughout gestation and lactation, HFD) on adult offspring metabolic, molecular and motor behavioural outcome. Our mouse model, utilising healthy nonobese MF1 mothers, induced distinct offspring outcomes dependent upon dietary duration with some sex-specific effects. EmbHFD offspring had high serum leptin (females), elevated systolic blood pressure (SBP), low locomotory activity and diminished motor coordination. Similarly, HFD offspring not only had raised serum leptin, high SBP and poor motor coordination but also experienced excess weight gain, deficits in energy metabolism, reduced relative brown adipose tissue (BAT) mass (females) and increased muscle lipid accumulation. Transcriptomic profiling of HFD female offspring revealed upregulation of thermogenic and lipid-handling genes (e.g., <i>Ucp1</i> and <i>ApoE</i>) in BAT alongside downregulation of mitotic regulators, suggesting impaired regenerative capacity. Collectively, these findings demonstrate, first, the risk to offspring of even transient maternal fatty diet without maternal obesity. Second, they highlight the sensitivity of periconceptional nutrition on the emergence of offspring multisystem metabolism and physiology, supporting the Developmental Origins of Health and Disease (DOHaD) concept.</p>","PeriodicalId":16587,"journal":{"name":"Journal of Nutrition and Metabolism","volume":"2026 ","pages":"5286440"},"PeriodicalIF":4.0,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13625825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149111037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"<i>In Vitro</i> and <i>In Vivo</i> Antidiabetic Effects of <i>Cratoxylum formosum</i> Leaf Extract in Low-Dose Streptozotocin- and High-Fat Diet-Induced Diabetic Mice.","authors":"Nipaporn Muangchan, Suwattanee Kooptiwut, Anchalee Vattarakorn, Bancha Yingngam, Kanchana Suksri","doi":"10.1155/jnme/8893700","DOIUrl":"https://doi.org/10.1155/jnme/8893700","url":null,"abstract":"<p><p><i>Cratoxylum formosum</i> (CF) is a phenolic-rich plant and exhibits <i>in vitro</i> antioxidant properties, yet its in vivo therapeutic potential remains uncharacterized. This study evaluated the antidiabetic efficacy of an ethanolic CF leaf extract using high-fat diet/streptozotocin-induced diabetic mice, complemented by enzymatic and INS-1 rat insulinoma cell line assays. This study found that 5-O-caffeoylquinic acid (5-CQA) was identified as the major phenolic compound in the CF leaf extract. In vitro, CF extract inhibited α-amylase and α-glucosidase activities and protected INS-1 cells from high-glucose-induced cytotoxicity. In diabetic mice, CF extract administration attenuated hyperglycemia, partially preserved serum insulin and C-peptide levels, and suppressed serum neuropeptide Y (NPY) concentrations. Histological analysis confirmed the preservation of pancreatic islet architecture and pancreatic β-cell mass. These findings indicate that CF extract supports glycemic regulation and pancreatic β-cell preservation, warranting further exploration as a candidate for diabetes management.</p>","PeriodicalId":16587,"journal":{"name":"Journal of Nutrition and Metabolism","volume":"2026 ","pages":"8893700"},"PeriodicalIF":4.0,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13625824/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149111021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Christopher R D'Adamo, Michelle Leary, Christopher Mote, Ronald Ackerman, Mark Holthouse, Brandilyn Binstock, Ellie Adair, Gabriela Piedrahita, Scott Wehage, Kristine Burke
{"title":"A Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Effects of Commercially Available Ubiquinone, Ubiquinol, and Geranylgeraniol Dietary Supplements on Plasma CoQ10 Concentrations.","authors":"Christopher R D'Adamo, Michelle Leary, Christopher Mote, Ronald Ackerman, Mark Holthouse, Brandilyn Binstock, Ellie Adair, Gabriela Piedrahita, Scott Wehage, Kristine Burke","doi":"10.1155/jnme/5589963","DOIUrl":"10.1155/jnme/5589963","url":null,"abstract":"<p><strong>Background: </strong>Coenzyme Q10 (CoQ10) plays a fundamental role in energy production and antioxidant activity in humans. Direct supplementation with both the ubiquinol and ubiquinone forms of CoQ10 increases circulating concentrations, although comparative efficacy remains uncertain. Furthermore, nutrients supporting endogenous CoQ10 production, such as geranylgeraniol (GG), suggest that supplementation may indirectly increase CoQ10 concentrations.</p><p><strong>Methods: </strong>A randomized, double-blind, parallel-arm, placebo-controlled trial was conducted comparing 8 weeks of label-dose supplementation with commercially available formulations of (1) ubiquinone; (2) ubiquinol; (3) GG; (4) ubiquinol + GG; and (5) placebo among healthy adults. The primary outcome was plasma CoQ10 concentrations. Secondary outcomes included lipid concentrations, markers of kidney and liver function, and validated questionnaires (PROMIS-Global Health, Profile of Mood States-Vigor subscale, and SF-36 Vitality subscale) assessing physical and mental health. Mean changes were compared across study arms using analysis of covariance (ANCOVA). Bonferroni correction for multiple comparisons was applied to the comparisons to placebo, and statistical significance was set at <i>p</i> < 0.0125. Tukey's multiple comparison procedure was applied to comparisons between each of the active study products, and statistical significance was set at <i>p</i> < 0.05.</p><p><strong>Results: </strong>A total of 150 participants were randomized. The mean age was 52.1 years, and the sample was diverse with respect to sex and race/ethnicity. Changes in CoQ10 with ubiquinone (+ 1.46), ubiquinol (+ 2.29), and ubiquinol + GG (+ 2.45) were greater than placebo (<i>p</i> < 0.0001). There were no differences between GG and placebo, ubiquinone and ubiquinol, or ubiquinol and ubiquinol + GG (<i>p</i> ≥ 0.15). Ubiquinol + GG (+ 0.99 mg/L) outperformed ubiquinone (<i>p</i> = 0.045). There were no differences versus placebo in questionnaires (<i>p</i> > 0.16). Adverse events were rare across all study arms.</p><p><strong>Conclusions: </strong>Supplementation with ubiquinone, ubiquinol, and ubiquinol + GG was well-tolerated and increased CoQ10 concentrations among healthy adults. While GG had no independent effects on CoQ10 concentrations, an interaction effect cannot be excluded, and this should be evaluated in a future factorial trial specifically designed for this purpose. Future studies evaluating the impact of ubiquinone + GG may also be warranted. <b>Trail Registration:</b> ClinicalTrials.gov: NCT06640465.</p>","PeriodicalId":16587,"journal":{"name":"Journal of Nutrition and Metabolism","volume":"2026 ","pages":"5589963"},"PeriodicalIF":4.0,"publicationDate":"2026-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13617315/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149074704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shengcai Yu, Xiangmin Ni, Haoyu Li, Heng Lu, Meng Ran Shi, Wenyi Zhu, Rong Fan, Xinyu Liang, Guiming Zhang, Jian Wang
{"title":"S-Equol Alleviates Palmitic Acid-Induced Muscle Atrophy by Modulating the ERβ-AMPK-Autophagy Axis in L6 Cells.","authors":"Shengcai Yu, Xiangmin Ni, Haoyu Li, Heng Lu, Meng Ran Shi, Wenyi Zhu, Rong Fan, Xinyu Liang, Guiming Zhang, Jian Wang","doi":"10.1155/jnme/9719495","DOIUrl":"10.1155/jnme/9719495","url":null,"abstract":"<p><strong>Background: </strong>Diabetic sarcopenia arises from metabolic imbalance-induced ROS accumulation and oxidative stress, which exacerbate muscle degeneration. Typically, autophagy removes excessive ROS and damaged organelles, helping to limit oxidative stress and preserve skeletal muscle function. S-Equol (Eq), an intestinal metabolite of soy isoflavones with high affinity for estrogen receptor <i>β</i> (ERβ), exhibits estrogen-like activity, yet its role in diabetic muscle atrophy remains unclear.</p><p><strong>Objectives: </strong>This study investigated the effects of Eq on diabetic muscle atrophy in PA-induced atrophic L6 myotubes.</p><p><strong>Methods: </strong>Here, palmitic acid (PA)-treated L6 myotubes were used to model diabetes-associated atrophy. Then, Eq treatment was further carried out, and oxidative stress, mitochondrial morphology, and autophagy were further detected.</p><p><strong>Results: </strong>PA suppressed AMPK/ULK1-mediated autophagy, induced ROS accumulation, disrupted mitochondrial morphology, and caused myotube atrophy. Eq treatment restored autophagic activity, significantly decreased ROS and malondialdehyde levels, maintained mitochondrial integrity and function, and preserved myotube structure. Importantly, inhibition of autophagy with 3-MA abolished the protective effects of Eq, confirming that its antiatrophic actions are autophagy-dependent. Mechanistically, knockdown of ERβ or AMPK prevented Eq from activating autophagy, suggesting that the ERβ-AMPK signaling axis is involved in Eq-mediated autophagy regulation.</p><p><strong>Conclusions: </strong>Our findings demonstrate that Eq alleviates PA-induced myotube atrophy by promoting autophagy, potentially through modulation of the ERβ-AMPK signaling axis. These results highlight Eq as a potential nutritional therapy for the prevention and treatment of diabetic sarcopenia.</p>","PeriodicalId":16587,"journal":{"name":"Journal of Nutrition and Metabolism","volume":"2026 ","pages":"9719495"},"PeriodicalIF":4.0,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13601852/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149039412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}